Tag: <span>vasculitis patients</span>

Home / vasculitis patients
Avacopan reduces need for glucocorticoids, respiratory and ENT involvement for vasculitis patients
Post

Avacopan reduces need for glucocorticoids, respiratory and ENT involvement for vasculitis patients

by American Thoracic Society Credit: Pixabay/CC0 Public Domain Avacopan was better than prednisone in reducing respiratory as well as ear, nose and throat (ENT) involvement in ANCA-associated vasculitis patients participating in the phase 3 ADVOCATE trial, and enabled reduced glucocorticoid use. Study results were published at the ATS 2022 international conference. The study was a...